We use necessary cookies that allow our site to work. We also set optional cookies that help us improve our website.

For more information about the types of cookies we use, and to manage your preferences, visit our Cookies policy here.

Cookie settings

Hear from the team behind OvarianVax

Early findings and what the HPV vaccine programme can teach us

Join us for an exclusive first look at the progress of OvarianVax, a pioneering research programme aiming to develop the world’s first vaccine to prevent ovarian cancer.

Event details

📅 Date: 21 May
⏰ Time: 2:00pm (UK time)
📍 Location: Online webinar

If you can’t join live, a recording will be shared afterwards.

Ahmed and Ovarian Cancer Action

L-R: Professor Ahmed Ahmed, Cary Wakefield, Marie-Claire Platt, Faye Hobbs

In this 45 min webinar, Professor Ahmed Ahmed (University of Oxford) will share early insights from the OvarianVax project, explaining what the team is working towards, what they’ve discovered so far and what still lies ahead.

He’ll be joined by Professor Peter Sasieni (Wolfson Institute of Population Health), a leading expert in cancer prevention, who will reflect on the success of the HPV vaccine programme and what it teaches us about turning promising science into real-world impact.

Together we’ll explore:

  • What would it take for a preventative ovarian cancer vaccine to succeed?
  • What drives public trust and uptake?
  • And what challenges still need to be overcome?

This session is designed for anyone with an interest in ovarian cancer, prevention, or the future of cancer research, whether you have a personal connection or are simply curious about what’s possible.

Find out more about OvarianVax